Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|16|3|246-253

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.16, Iss.3, 2018-03, pp. : 246-253

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NAFLD-NASH: An Under-Recognized Epidemic

By  

Current Vascular Pharmacology, Vol. 16, Iss. 3, 2018-03 ,pp. : 209-213

Bentham Science Publishers

Access to resources Recommend Favorite

Tocopherols in the Prevention and Treatment of Atherosclerosis and Related Cardiovascular Disease

By  

Clinical Cardiology, Vol. 160-9289, Iss. 9, 2015-09 ,pp. : 570-576

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tocopherols in the Prevention and Treatment of Atherosclerosis and Related Cardiovascular Disease

By  

Clinical Cardiology, Vol. 38, Iss. 9, 2015-09 ,pp. : 570-576

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk and Benefit of Statins in Stroke Secondary Prevention

By  

Current Vascular Pharmacology, Vol. 11, Iss. 6, 2013-11 ,pp. : 812-816

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Role of NPC1L1 in the Regulation of Hepatic Metabolism: Potential Contribution of Ezetimibe in NAFLD/NASH Treatment

By  

Current Vascular Pharmacology, Vol. 9, Iss. 1, 2011-01 ,pp. : 121-123

Bentham Science Publishers

Access to resources Recommend Favorite